UBS Group’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,683
| Closed | -$842 | – | 8936 |
|
|
2023
Q1 | $842 | Sell |
2,683
-4,985
| -65% | -$1.56K | ﹤0.01% | 7788 |
|
|
2022
Q4 | $9.05K | Buy |
7,668
+4,471
| +140% | +$5.28K | ﹤0.01% | 7503 |
|
|
2022
Q3 | $3K | Sell |
3,197
-5,096
| -61% | -$4.78K | ﹤0.01% | 8538 |
|
|
2022
Q2 | $9K | Buy |
+8,293
| New | +$9K | ﹤0.01% | 7180 |
|
|
2021
Q3 | – | Sell |
-3,229
| Closed | -$24K | – | 9034 |
|
|
2021
Q2 | $24K | Buy |
+3,229
| New | +$24K | ﹤0.01% | 6077 |
|
|
2021
Q1 | – | Sell |
-454
| Closed | -$3K | – | 8382 |
|
|
2020
Q4 | $3K | Sell |
454
-131
| -22% | -$866 | ﹤0.01% | 7009 |
|
|
2020
Q3 | $4K | Sell |
585
-764
| -57% | -$5.22K | ﹤0.01% | 6576 |
|
|
2020
Q2 | $9K | Buy |
+1,349
| New | +$9K | ﹤0.01% | 6253 |
|
|
2020
Q1 | – | Sell |
-734
| Closed | -$3K | – | 7330 |
|
|
2019
Q4 | $3K | Sell |
734
-291
| -28% | -$1.19K | ﹤0.01% | 6699 |
|
|
2019
Q3 | $7K | Sell |
1,025
-1,038
| -50% | -$7.09K | ﹤0.01% | 6394 |
|
|
2019
Q2 | $21K | Buy |
2,063
+412
| +25% | +$4.19K | ﹤0.01% | 5712 |
|
|
2019
Q1 | $19K | Sell |
1,651
-375
| -19% | -$4.32K | ﹤0.01% | 5532 |
|
|
2018
Q4 | $22K | Buy |
2,026
+217
| +12% | +$2.36K | ﹤0.01% | 5795 |
|
|
2018
Q3 | $24K | Buy |
+1,809
| New | +$24K | ﹤0.01% | 5792 |
|